Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β‑catenin signaling pathways

Xiao,Wei; Chen,Xiaoyun; He,Mingguang

doi:10.3892/mmr.2014.2213

Inhibition of the Jagged/Notch pathway inhibits retinoblastoma cell proliferation via suppressing the PI3K/Akt, Src, p38MAPK and Wnt/β‑catenin signaling pathways

Authors:
- Wei Xiao
- Xiaoyun Chen
- Mingguang He
View Affiliations

Affiliations: State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat‑sen University, Guangzhou, Guangdong 510060, P.R. China
Published online on: May 6, 2014 https://doi.org/10.3892/mmr.2014.2213
Pages: 453-458

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The Notch signaling pathway is a highly conserved developmental pathway, which is important in the regulation of cellular proliferation, differentiation and apoptosis. The aberrant expression of the Notch pathway has been associated with carcinogenesis in various types of cancer. In order to investigate the expression profiles and biological functions of Notch receptors and ligands in retinoblastoma, the expression levels of their proteins in the human retinoblastoma cell line SO‑Rb50 using western blot analysis was assessed. The present study revealed that Notch1 and Jagged2 were highly expressed compared with human retinal pigment epithelial cells. When treated with DAPT, a specific inhibitor of Notch receptor cleavage, expression of Notch1 and Jagged2 were downregulated in a dose‑dependent manner, which was accompanied by substantial cell growth arrest, as indicated by the Cell Counting kit‑8 assay. In addition, phosphorylation of Akt, p38 mitogen‑activated protein kinase and Src, together with the expression of phosphoinositide 3‑kinase and β‑catenin, was abated in a dose‑dependent manner. However, expression of either total extracellular signal‑regulated kinase (Erk)1/2 or phospho‑Erk1/2 was not changed in SO‑Rb50 cells. These findings demonstrated that the Jagged2/Notch1 pathway can promote oncogenesis in retinoblastoma in co‑operation with multiple signaling pathways. The inhibition of the Notch signaling pathway by DAPT represents a potentially attractive strategy for the therapy of retinoblastoma.

View Figures

View References

1	Kivelä T: The epidemiological challenge of the most frequent eye cancer: retinoblastoma, an issue of birth and death. Br J Ophthalmol. 93:1129–1131. 2009.PubMed/NCBI
2	Rodriguez-Galindo C, Wilson MW, Chantada G, et al: Retinoblastoma: one world, one vision. Pediatrics. 122:e763–e770. 2008. View Article : Google Scholar : PubMed/NCBI
3	Friend SH, Bernards R, Rogelj S, et al: A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma. Nature. 323:643–646. 1986. View Article : Google Scholar : PubMed/NCBI
4	Corson TW and Gallie BL: One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma. Genes Chromosomes Cancer. 46:617–634. 2007. View Article : Google Scholar : PubMed/NCBI
5	Dimaras H, Khetan V, Halliday W, et al: Loss of RB1 induces non-proliferative retinoma: increasing genomic instability correlates with progression to retinoblastoma. Hum Mol Genet. 17:1363–1372. 2008. View Article : Google Scholar : PubMed/NCBI
6	Dyer MA and Bremner R: The search for the retinoblastoma cell of origin. Nat Rev Cancer. 5:91–101. 2005. View Article : Google Scholar : PubMed/NCBI
7	Kidd S, Lockett TJ and Young MW: The Notch locus of Drosophila melanogaster. Cell. 34:421–433. 1983. View Article : Google Scholar : PubMed/NCBI
8	Mullendore ME, Koorstra JB, Li YM, et al: Ligand-dependent Notch signaling is involved in tumor initiation and tumor maintenance in pancreatic cancer. Clin Cancer Res. 15:2291–2301. 2009. View Article : Google Scholar : PubMed/NCBI
9	Nam DH, Jeon HM, Kim S, et al: Activation of notch signaling in a xenograft model of brain metastasis. Clin Cancer Res. 14:4059–4066. 2008. View Article : Google Scholar : PubMed/NCBI
10	South AP, Cho RJ and Aster JC: The double-edged sword of Notch signaling in cancer. Semin Cell Dev Biol. 23:458–464. 2012. View Article : Google Scholar : PubMed/NCBI
11	Aguirre A, Rubio ME and Gallo V: Notch and EGFR pathway interaction regulates neural stem cell number and self-renewal. Nature. 467:323–327. 2010. View Article : Google Scholar : PubMed/NCBI
12	Zayzafoon M, Abdulkadir SA and McDonald JM: Notch signaling and ERK activation are important for the osteomimetic properties of prostate cancer bone metastatic cell lines. J Biol Chem. 279:3662–3670. 2004. View Article : Google Scholar : PubMed/NCBI
13	Ye YZ, Zhang ZH, Fan XY, et al: Notch3 overexpression associates with poor prognosis in human non-small-cell lung cancer. Med Oncol. 30:5952013. View Article : Google Scholar : PubMed/NCBI
14	Reichrath J and Reichrath S: Notch-signaling and nonmelanoma skin cancer: an ancient friend, revisited. Adv Exp Med Biol. 727:265–271. 2012. View Article : Google Scholar : PubMed/NCBI
15	Purow B: Notch inhibition as a promising new approach to cancer therapy. Adv Exp Med Biol. 727:305–319. 2012. View Article : Google Scholar : PubMed/NCBI
16	Miele L, Miao H and Nickoloff BJ: NOTCH signaling as a novel cancer therapeutic target. Curr Cancer Drug Targets. 6:313–323. 2006. View Article : Google Scholar : PubMed/NCBI
17	Bin Hafeez B, Adhami VM, Asim M, et al: Targeted knockdown of Notch1 inhibits invasion of human prostate cancer cells concomitant with inhibition of matrix metalloproteinase-9 and urokinase plasminogen activator. Clin Cancer Res. 15:452–459. 2009.
18	Chiron D, Maïga S, Descamps G, et al: Critical role of the NOTCH ligand JAG2 in self-renewal of myeloma cells. Blood Cells Mol Dis. 48:247–253. 2012. View Article : Google Scholar : PubMed/NCBI
19	Zhang TH, Liu HC, Zhu LJ, et al: Activation of Notch signaling in human tongue carcinoma. J Oral Pathol Med. 40:37–45. 2011. View Article : Google Scholar : PubMed/NCBI
20	Yang Y, Ahn YH, Gibbons DL, et al: The Notch ligand Jagged2 promotes lung adenocarcinoma metastasis through a miR-200-dependent pathway in mice. J Clin Invest. 121:1373–1385. 2011. View Article : Google Scholar : PubMed/NCBI
21	Rodilla V, Villanueva A, Obrador-Hevia A, et al: Jagged1 is the pathological link between Wnt and Notch pathways in colorectal cancer. Proc Natl Acad Sci USA. 106:6315–6320. 2009. View Article : Google Scholar : PubMed/NCBI
22	Chen SM, Liu JP, Zhou JX, et al: Suppression of the notch signaling pathway by gamma-secretase inhibitor GSI inhibits human nasopharyngeal carcinoma cell proliferation. Cancer Lett. 306:76–84. 2011. View Article : Google Scholar : PubMed/NCBI
23	Shao H, Huang Q and Liu ZJ: Targeting Notch signaling for cancer therapeutic intervention. Adv Pharmacol. 65:191–234. 2012. View Article : Google Scholar
24	Guo D, Ye J, Dai J, et al: Notch-1 regulates Akt signaling pathway and the expression of cell cycle regulatory proteins cyclin D1, CDK2 and p21 in T-ALL cell lines. Leuk Res. 33:678–685. 2009. View Article : Google Scholar : PubMed/NCBI
25	Liu ZJ, Xiao M, Balint K, et al: Notch1 signaling promotes primary melanoma progression by activating mitogen-activated protein kinase/phosphatidylinositol 3-kinase-Akt pathways and up-regulating N-cadherin expression. Cancer Res. 66:4182–4190. 2006. View Article : Google Scholar
26	Mungamuri SK, Yang X, Thor AD and Somasundaram K: Survival signaling by Notch1: mammalian target of rapamycin (mTOR)-dependent inhibition of p53. Cancer Res. 66:4715–4724. 2006. View Article : Google Scholar : PubMed/NCBI
27	Guo D, Teng Q and Ji C: NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia. Leuk Lymphoma. 52:1200–1210. 2011. View Article : Google Scholar : PubMed/NCBI
28	Mohan A, Mallikarjuna K, Venkatesan N, Abhyankar D, Parikh PM and Krishnakumar S: The study of c-Src kinase and pStat3 protein expression in retinoblastoma. Exp Eye Res. 83:736–740. 2006. View Article : Google Scholar : PubMed/NCBI
29	Ishizawar R and Parsons SJ: c-Src and cooperating partners in human cancer. Cancer Cell. 6:209–214. 2004. View Article : Google Scholar : PubMed/NCBI
30	Ma YC, Shi C, Zhang YN, et al: The tyrosine kinase c-Src directly mediates growth factor-induced Notch-1 and Furin interaction and Notch-1 activation in pancreatic cancer cells. PLoS One. 7:e334142012. View Article : Google Scholar : PubMed/NCBI
31	Chen YS, Wu MJ, Huang CY, Lin SC, Chuang TH, Yu CC and Lo JF: CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. PLoS One. 6:e280532011. View Article : Google Scholar : PubMed/NCBI
32	Reya T and Clevers H: Wnt signalling in stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
33	Tell S, Yi H, Jockovich ME, Murray TG and Hackam AS: The Wnt signaling pathway has tumor suppressor properties in retinoblastoma. Biochem Biophys Res Commun. 349:261–269. 2006. View Article : Google Scholar : PubMed/NCBI
34	Hahne G and Grossmann TN: Direct targeting of beta-catenin: Inhibition of protein-protein interactions for the inactivation of Wnt signaling. Bioorg Med Chem. 21:4020–4026. 2013. View Article : Google Scholar : PubMed/NCBI
35	Kondoh K, Sunadome K and Nishida E: Notch signaling suppresses p38 MAPK activity via induction of MKP-1 in myogenesis. J Biol Chem. 282:3058–3065. 2007. View Article : Google Scholar : PubMed/NCBI